Brief: India's Caplin Point Laboratories March-qtr consol profit more than doubles
May 10 (Reuters) - Caplin Point Laboratories Ltd CAPL.NS
* March quarter consol net profit 334.1 million rupees
versus 155.8 million rupees year ago
* March quarter consol net sales 1.18 billion rupees versus
819.1 million rupees year ago
Source text for Eikon: ID:nBSE31ytqZ
Further company coverage: CAPL.NS
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Caplin Point Laboratories
See all newsBrief: Caplin Point Laboratories Says US FDA Completes Unannounced Inspection Of Caplin Steriles Gummidipoondi Facility
Brief: Caplin Point Laboratories March-Quarter Consol Net Profit 1.7 Bln Rupees
Brief: Caplin Point Laboratories Unit Receives Final USFDA Approval For ANDA Potassium Phosphates Injection
Brief: Caplin Point Laboratories Says Unit Receives USFDA Approval For Sodium Phosphates Injection
Brief: Caplin Point Laboratories Dec-Quarter Consol Net Profit 1.64 Billion Rupees